Stock listing
NSB Stock Price, News, Filings & Events — Neuroscientific Biopharmaceuticals Ltd.
Selected listing: NSB · ASX · AUD · AU
This page tracks Neuroscientific Biopharmaceuticals Ltd.'s NSB:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NSB:ASX. NSB:ASX is the stock-level entry point for investors researching Neuroscientific Biopharmaceuticals Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Neuroscientific Biopharmaceuticals Ltd. (ticker: NSB) is a public company listed on the Australian market, with a market capitalization of approximately AUD 17.72 million. The company focuses on developing innovative biopharmaceutical products aimed at addressing neurological disorders. Its commitment to research and development positions it within the growing biopharmaceutical sector.

- Ticker
- NSB:ASX
- Asset type
- Stock
- Market cap
- $18.3M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- ASX
- Currency
- AUD
Neuroscientific Biopharmaceuticals Ltd. NSB:ASX stock context
This page tracks Neuroscientific Biopharmaceuticals Ltd.'s NSB:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NSB:ASX. NSB:ASX is the stock-level entry point for investors researching Neuroscientific Biopharmaceuticals Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Neuroscientific Biopharmaceuticals Ltd. (ticker: NSB) is a public company listed on the Australian market, with a market capitalization of approximately AUD 17.72 million. The company focuses on developing innovative biopharmaceutical products aimed at addressing neurological disorders. Its commitment to research and development positions it within the growing biopharmaceutical sector.
Latest news from Neuroscientific Biopharmaceuticals Ltd.
2026 Annual Report & Appendix 4E
August 25, 2026
Remarkable Results from Patients treated with StemSmart
May 25, 2026
Half Yearly Report and Accounts
February 25, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
January 29, 2026
Successful Clinical Results Achieved under Special Access
January 12, 2026
Research Neuroscientific Biopharmaceuticals Ltd.
Neuroscientific Biopharmaceuticals Ltd. investor report
Review AI stock analysis and investor report context for NSB:ASX.
Neuroscientific Biopharmaceuticals Ltd. company profile
View the public company page for Neuroscientific Biopharmaceuticals Ltd. on 6ix.
Neuroscientific Biopharmaceuticals Ltd. news
Read company news and market updates connected to Neuroscientific Biopharmaceuticals Ltd..
Neuroscientific Biopharmaceuticals Ltd. investor events
Find investor webinars, events, and replay context for Neuroscientific Biopharmaceuticals Ltd..